中文(简体)
Albanian
Arabic
Armenian
Azerbaijani
Belarusian
Bengali
Bosnian
Catalan
Czech
Danish
Deutsch
Dutch
English
Estonian
Finnish
Français
Greek
Haitian Creole
Hebrew
Hindi
Hungarian
Icelandic
Indonesian
Irish
Italian
Japanese
Korean
Latvian
Lithuanian
Macedonian
Mongolian
Norwegian
Persian
Polish
Portuguese
Romanian
Russian
Serbian
Slovak
Slovenian
Spanish
Swahili
Swedish
Turkish
Ukrainian
Vietnamese
Български
中文(简体)
中文(繁體)

Prospective Aerobic Reconditioning Intervention Study

只有注册用户可以翻译文章
登陆注册
链接已保存到剪贴板
状态已完成
赞助商
Wake Forest University
合作者
National Institutes of Health (NIH)
National Institute on Aging (NIA)

关键词

抽象

The purpose of this study is :
- To determine if aerobic exercise conditioning can improve symptoms, cardiovascular function and quality of life in elderly patients with congestive heart failure.
- To describe the baseline clinical characteristics, cardiovascular function and neurohumoral function in elderly patients with congestive heart failure.
- To determine the specific cardiovascular and noncardiovascular mechanisms by which symptoms and quality of life may improve following exercise conditioning in elderly patients with congestive heart failure.

描述

In patients over age 65, cardiovascular disease accounts for the largest percentage of deaths, hospital days, doctor visits, and overall health care expenditures. In addition, heart failure is the most common discharge diagnosis in the elderly. Heart failure can be defined as a state in which cardiac output is insufficient to meet metabolic demands. This is most frequently manifested by symptoms of fatigue and dyspnea. Inherent in this definition is that symptoms may be increased or only occur during times when metabolic demand is increased, such as during exercise. As such, exercise intolerance is a hallmark of the heart failure syndrome. Exercise intolerance correlates not only with disease severity and also with subsequent mortality. Exercise tolerance can be objectively quantified during maximal symptom limited standardized exercise protocols by analysis of exercise time, workload, METS (metabolic equivalents), and oxygen consumption (V02)' These measures have appropriately become accepted as standards for functional assessment in this disorder as well as outcome measures following therapeutic interventions in HF. P.A.R.I.S. is a randomized, attention-controlled, single-blind trial of supervised aerobic exercise training in older patients with heart failure. The primary outcome is exercise capacity and the main secondary outcome is quality of life. Mechanistic outcomes were also examined. In PARIS, which focused on cardiac mechanisms, there were HFPEF and HFREF patients studied in parallel. In PARIS-II, there were only HFPEF patients which focused on vascular mechanisms.

Main outcomes have been reported (see citations below).

日期

最后验证: 01/31/2019
首次提交: 04/28/2010
提交的预估入学人数: 04/28/2010
首次发布: 04/29/2010
上次提交的更新: 02/11/2019
最近更新发布: 02/14/2019
实际学习开始日期: 06/30/1993
预计主要完成日期: 11/30/2004
预计完成日期: 11/30/2009

状况或疾病

Heart Failure

干预/治疗

Behavioral: Exercise

Behavioral: Control

-

手臂组

干预/治疗
Placebo Comparator: Control
Control group continues with their daily activity as they were prior to randomization. Receive bi-weekly follow-up phone calls to assess health status and encourage adherence with protocol.
Behavioral: Control
Control group continues daily life as prior to randomization.
Active Comparator: Exercise
Exercise classes three times per week in a controlled, supervised environment.
Behavioral: Exercise
Exercise classes three times per week in a controlled, supervised environment.

资格标准

有资格学习的年龄 60 Years 至 60 Years
有资格学习的性别All
接受健康志愿者
标准

Inclusion Criteria:

- Age greater than or equal to 60 years of age

- Symptoms of congestive heart failure

- Able to understand and give informed consent

Exclusion Criteria:

- Age <60 years

- Does not have CHF

- Significant change in cardiac medication <3 weeks

- Myocardial infarction <3 weeks

- CABG surgery <3 months

- Angina pectoris not controlled during daily activity by pharmacological therapy or at <4 METS activity

- Sustained hypertension with systolic> 190 and diastolic> 110 on medications

- Valvular heart disease as the primary etiology of CHF

- Significant aortic stenosis

- Stroke of <3 months or with any physical restriction impairment that would prevent participation in exercise programs

- Chronic obstructive pulmonary disease on therapy that limits exercise duration

- Uncontrolled diabetes mellitus

- Active treatment for cancer or other noncardiovascular conditions with life expectancy less than three years

- Anemia "10 gms Hb)

- Renal insufficiency (cr >2.5 mg/dl)

- Psychiatric disease - uncontrolled major psychoses, depressions, dementia, or personality disorder

- Dementia - MMSE ~24 "22 for ~8th grade education)

- Lack of an acoustic window sufficient to allow definition of endocardial borders on the screening echocardiogram.

- Plans to leave area or be admitted to a nursing home within 2 years.

- Inability to walk at least 420 feet in 6 minutes without a cane or other assistive device.

- Inability to exercise at or near home.

- At the discretion of the clinical staff, it is believed that the participant cannot or will not complete the protocol because of frailty, illness, or other reason.

- Participation in a regular exercise regimen more than one time per week for at least twenty minutes per session; including but not limited to walking, swimming, weight lifting, golfing, or taking an exercise class.

- Inability to ambulate without cane or other assistive device during biomechanics testing or treadmill.

- Inability to attend at least fourteen weeks of the facility-based intervention

结果

主要结果指标

1. Peak exercise capacity [16 weeks]

次要成果指标

1. Quality of life [16 weeks]

加入我们的脸书专页

科学支持的最完整的草药数据库

  • 支持55种语言
  • 科学支持的草药疗法
  • 通过图像识别草药
  • 交互式GPS地图-在位置标记草药(即将推出)
  • 阅读与您的搜索相关的科学出版物
  • 通过药效搜索药草
  • 组织您的兴趣并及时了解新闻研究,临床试验和专利

输入症状或疾病,并阅读可能有用的草药,输入草药并查看所使用的疾病和症状。
*所有信息均基于已发表的科学研究

Google Play badgeApp Store badge